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Background/aim: The aim of this study was to investigate neuroendocrine tumors (NETs) detected in appendectomy specimens and
the incidence and clinicopathologic characteristics of these tumors in our center.
Materials and methods: A total of 13,863 patients were evaluated retrospectively. All underwent appendectomy operation in the Kayseri
Training and Research Hospital and had a histopathological examination at the Pathology Clinic between January 2007 and March 2017.
Age, sex, preoperative clinical findings, operation procedure, and histopathological examination results of the cases reported to be NET
are presented.
Results: NET was detected in 29 cases (0.2%) in the histopathological examination of 13,863 appendectomy specimens. Of these, 26
were classical carcinoid tumors and 3 were goblet cell carcinoid tumors (GCCTs). For the NET cases, the mean age was 37 years and the
male to female ratio was 1.07. Only 68.9% of the patients underwent an appendectomy, and 31% of the patients underwent a secondary
right hemicolectomy. Recurrences were not detected in any of the cases. In the present study, coincidence was determined in all of the
cases with NET in the appendix.
Conclusion: Contrary to many studies, both NETs of the appendix and GCCT cases were slightly higher among males and advanced age
groups in this study. The long-term life expectancy in cases of classical carcinoid tumors of the appendix is quite good.
Key words: Appendix, carcinoid tumor, goblet cell carcinoid tumor, neuroendocrine tumor

1. Introduction
Carcinoid tumors are rare, slow-growing neuroendocrine
tumors arising from the enterochromaffin cells
disseminated throughout the gastrointestinal and
bronchopulmonary system (1). The gastrointestinal
system has the largest proportion of neuroendocrine cells
(2). However, neuroendocrine tumors (NETs) account for
only 2% of all gastrointestinal system malignancies (3).
NETs are most commonly observed in the small intestine,
followed by the rectum and appendix (4). The biological
behavior of these tumors is not fully understood (5).
Carcinoid tumors of the appendix are clinically silent and
detected incidentally in appendectomy specimens (6).
NETs of the appendix are divided into two categories
based on complete or partial neuroendocrine cells:
classical carcinoid tumors and goblet cell carcinoid
tumors (GCCTs) and their variants (7). Classical carcinoid
tumors include neuroendocrine differentiation. Tumors
are called GCCT when they contain both glandular and
* Correspondence: drfatmasenel2@gmail.com
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neuroendocrine differentiations (8). Goblet cell carcinoids
originate from pluripotent intestinal stem cells that show
both neuroendocrine and mucinous differentiations
(9,10). GCCT is also known as adenocarcinoid, mucinous
carcinoid, and crypt cell carcinoid tumors (9). The
prognosis of classical carcinoid tumors is very good (11).
GCCT follows a more aggressive course than classical
carcinoid tumors (10).
In this study, we investigated the NETs found in the
appendectomy materials of patients who had undergone
an appendectomy in our center and the characteristics of
these tumors.
2. Materials and methods
A total of 13,863 patients were evaluated retrospectively.
All underwent appendectomies in the Kayseri Training
and Research Hospital and had histopathological
examinations between January 2007 and March 2017.
Patients diagnosed with NET were included in the
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study. Patient information was obtained from computer
records and phone calls when required. The age, sex,
preoperative clinical findings, operative procedure, and
histopathological and immunohistochemical findings of
these cases were recorded. In terms of treatment, a right
hemicolectomy was applied if there was mesoappendix
invasion in appendiceal NETs, if the tumor was larger
than 2 cm, if there was mesoappendiceal lymph node
metastasis, if there was a goblet cell component, or if
the tumor continued within the surgical margin of the
appendix.
NET cases were followed by ultrasonography and
gallium 68 PET-CT in the postoperative 6th and 12th
months and then annually while they were followed
lifelong for recurrences. The follow-up period was
calculated as the period starting from the date of diagnosis
to either the date of relapse or the date of the last followup. The patients were followed for a mean period of 5 years
(0.5–9.5 years)
The study was approved by the local ethics committee
of Kayseri Training and Research Hospital (ID: 05).

3. Results
There were 29 NET cases (0.2%) in the 10-year archive.
Of these, 26 were classical carcinoid and 3 were GCCT
cases. Fifteen patients (51.7%) were male and 14 (48.2%)
were female. The mean age was 37 years (range: 12–78
years). All 3 GCCT patients were male and the mean age
was 67 years (range: 56–76 years). There was clinically
acute appendicitis in 27 NET patients (93%). One
patient (3.4%) was operated on due to an ovarian cyst
and one (3.4%) was operated on due to a polyp in the
colon.
Tumors were located in the distal part of the appendix
in 86% of the cases, at the proximal end in 3.4% of cases,
and in the middle part in 10.3% of cases. Tumors were
smaller than 1 cm in 69% of the cases, between 1 and 2 cm
in 27.5% of cases, and larger than 2 cm in 3.4% of cases.
The tumor penetration depth was in the submucosa
or muscular layer in 51% of the cases, in the serosa in
20.6% of cases, and in the mesoappendix in 27.5% of
cases (Table). Fifteen cases (51.7%) were accompanied
by acute appendicitis as a histopathological finding.

Table. Clinicopathological characteristics.
CCT (n = 26)

GCCT (n = 3)

37 (12–78)

67 (56–76)

Female

14

0

14 (48.2)

Male

12

3

15 (51.7)

Mucosal layer

15

0

15 (51)

Serosal layer

6

0

6 (20.6)

Mesoappendix

5

3

8 (27.5)

<1 cm

20

0

20 (69)

1–2 cm

5

3

8 (27.5)

>2 cm

1

0

1 (3.4)

Distal

22

3

25 (86)

Proximal

1

0

1 (3.4)

Body

3

0

3 (10.3)

Appendectomy

20

0

20 (68.9)

Secondary right hemicolectomy

6

3

9 (31)

Age, median (range)

Total (n = 29) (%)

Sex, no.

Tumor localization

Tumor size

Extension

Treatment

CCT: Classical carcinoid tumor.
GCCT: Goblet cell carcinoid tumor.
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In histopathological examination, classical carcinoid
tumor cases were observed. There were cells with a small
round nucleus and narrow cytoplasm forming small
islands and cord-like structures (Figure 1). All of the
cases were immunohistochemically studied with some
neuroendocrine markers such as neuron-specific enolase
(NSE) (Figure 2), chromogranin, and synaptophysin;
positive staining was observed in all cases. None of the
cases had lymphovascular or perineural invasion. The
Ki67 index was 1%–2%.
In the GCCT cases, tumors had extensive, eosinophilic,
and granular cytoplasm and were characterized by
microglandular small goblet cell islands with eccentric
nuclei (Figure 3). Positive staining was obtained with
both epithelial markers such as CK7 and CK20 (Figure
4A) and chromogranin-A (Figure 4B) and NSE among
neuroendocrine markers. Perineural invasion was
observed in 2 of the cases. The Ki67 index was 3%–10%.
Of the NET patients, 68.9% underwent appendectomies
and 31% underwent secondary right hemicolectomies.
The patients were followed for a mean period of 5
years (0.5–9.5 years) with abdominal ultrasonography and
gallium 68 PET-CT in terms of recurrences. Recurrences
were not detected in any of the patients. None of the
patients died due to NET. One patient died from heart
failure 5 years after an appendectomy.
4. Discussion
Carcinoid tumors originate from enterochromaffin cells,
a type of neuroendocrine cells in the lamina propria and
submucosa (12). The incidence of appendiceal NETs
is reported to be between 0.27% and 1.6% (13,14). It is
reported that the mean age of patients at diagnosis is the

Figure 1: Hematoxylin and eosin-stained sections showing the
tumor itself is composed of small round nucleus and narrow
cytoplasm forming small islands and cord-like structures (H&E,
200×).
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Figure 2. In the immunohistochemical studies, strong positivity
for neuroendocrine cell component marker NSE was detected in
the tumor (IHC, 200×).

late second decade (4,15) and the ratio of males to females
is 1:2–4 (16). The incidence of appendiceal NETs is 0.2%
in this study, and the mean age is higher (37 years) and
the ratio is slightly higher for males (M:F = 1.07), as
highlighted in previous studies (4,15,16).
In the literature, GCCTs are reported to be 6% of
all appendiceal NETs (7,17). This rate is higher in the
present study, where GCCT cases constitute 10.3% of all
appendiceal NETs. It has been reported that GCCTs are
observed at the same frequency in both males and females
and the mean age at diagnosis is the 5th decade (18).
Contrary to these studies, 3 of our GCCT patients are male
and are older than average (mean age: 67 years).
The WHO 2010 classification uses the ENETS
grading criteria (8). In 2010, the WHO and the European
Neuroendocrine Tumor Society (ENETS) divided the
grade of NETs into three groups based on the Ki67
proliferation index and the number of mitoses. If there
are less than two mitoses in 10 HPF and the Ki67 index
is less than 2%, it is called “NET, low grade (Grade 1)”.
If there are 2–20 mitoses and a Ki67 index of 3%–20%,
it is called “NET, moderate-grade (Grade 2)”. If there are
more than 20 mitoses with a Ki67 index greater than 20%,
it is classified as “neuroendocrine carcinoma, high grade
(Grade 3)” (8,10).
Carcinoid tumors of the appendix are generally
asymptomatic due to their small size and are often identified
incidentally during the histopathological examination of
appendectomy materials (19). Sometimes NETs localized
at the base of the appendix, depending on the site, may
block the lumen and cause clinical acute appendicitis (15).
In this study, 93% of NET patients were operated on with
acute appendicitis.
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Figure 3. Hematoxylin and eosin-stained sections showing the
tumor itself is composed of small uniform tumor nests of goblet
cells often arranged in a microglandular fashion (H&E, 200×).

In general, 50% of GCCT patients present with
abdominal pain and palpable mass (17). Others are
identified incidentally, from the appendectomy materials of
patients operated on with a diagnosis of acute appendicitis,
like in the present study (9,10). Perforated appendicitis
is reported in 27% of GCCT cases (19). Perforated
appendicitis was observed in 33% of the GCCT cases in
this study. The effect of perforated acute appendicitis
in GCCT cases has not been clarified. In a retrospective
series of 20 GCCT patients with perforated appendicitis,
a lower rate of peritoneal metastases was observed in the
perforated group (15%) compared to the nonperforated
group (42%) with no difference in peritoneal relapse
between the two groups (19). Classical carcinoid cases show
neuroendocrine morphology, and GCCT includes goblet
cell morphology as well as neuroendocrine morphology.

Both types of carcinoid tumors show neuroendocrine
marker expression immunohistochemically. In GCCT,
cytokeratins such as CK7 and CK20 are expressed, as in
colonic adenocarcinoma, but they are not expressed in
classical carcinoid tumors (20). In addition to classical
histological images, GCCT cases show extensive invasion
and perineural invasion in the mesoappendix, as in our
cases (21).
The majority of NETs are observed in the distal part of
the appendix, as in the present study, because the majority
of neuroendocrine cells are located in this region (22).
Approximately 80% of appendiceal NETs are smaller than
1 cm in diameter (23). In the current study, 69% of the
appendiceal NETs were of this size.
In terms of treatment, a right hemicolectomy is
recommended if there is mesoappendix invasion in
appendiceal NETs, if the tumor is larger than 2 cm, if there
is mesoappendiceal lymph node metastasis, if there is a
goblet cell component, or if the tumor continues within
the surgical margin of the appendix. If there is no local
metastasis, appendectomy is sufficient for tumors smaller
than 2 cm. A right hemicolectomy is recommended in
young patients with tumors larger than 2 cm, although
there is no lymph node metastasis. A more conservative
approach is recommended in elderly patients because the
tumor develops more slowly (24).
Appendiceal carcinoid tumors of less than 1 cm in
diameter have an excellent prognosis and are adequately
treated by appendectomy alone. The risk of metastasis is
0% in appendiceal carcinoid tumors smaller than 1 cm,
whereas it is 2%–18% in the small intestine and 0%–20%
in the rectum. Moertel found no recurrences and no
metastases among 108 patients with a tumor size of less
than 1 cm. However, there was a tumor recurrence of 80%
in patients with lesions greater than 2 cm in diameter (25).

Figure 4. A) Tumor cells exhibit strong immunoreactivity for CK20 (IHC, 200×). B) In the immunohistochemical studies strong
positivity was detected in the tumor for neuroendocrine cell component marker chromogranin-A (IHC, 200×).
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The recommended treatment for goblet cell carcinoid
is a right hemicolectomy, especially if the tumor has
spread beyond the appendix or shows a high mitotic
count. Although many authors suggest a routine
right hemicolectomy for goblet cell carcinoids, this
recommendation has been questioned, and some authors
believe that appendectomy alone may be sufficient if
the appendiceal margin is clear, there is no evidence
of spread into the periappendiceal soft tissue, and the
mitotic count is no more than two mitoses per 10 HPF
(9,26,27). Both the European and the North American
Neuroendocrine Tumor Society guidelines recommend a
right hemicolectomy after appendectomy due to the high
rate of metastases and its impact on prognosis (28).
Twenty of our NET patients underwent only an
appendectomy operation. Nine patients underwent a
secondary right hemicolectomy. Eight patients underwent
a right hemicolectomy due to mesoappendiceal invasion,
and 3 of them were GCCT patients. One patients
underwent a right hemicolectomy because there was a
tumor at the surgical margin of the appendix.
The prognosis for classical carcinoid tumors is very
good. If the tumor is localized in the appendix, the 5-year
survival rate is 94% (29). The most common metastasis
in NETs is the right colon and ileum with the direct

extension, followed by lymph nodes, the peritoneum, and
the omentum, respectively (26).
GCCTs follow a more aggressive course than classical
carcinoid tumors. If the tumor in a case of GCCT is limited
to the appendix, the 5-year survival rate is 50%–80%, but
it is less than 10% in the presence of distant metastasis.
Approximately 10% of GCCT cases have liver, ovarian,
or peritoneal metastasis during diagnosis (10). When a
mucinous tumor is observed in the ovary in GCCT cases,
it should be kept in mind that this may be the primary
tumor of the ovary or the ovarian spread of GCCT.
GCCTs of appendiceal origin express elevated MUC2 and
MUC5AC. In contrast, mucinous tumors arising from
ovarian primaries express only MUC5AC (30). This could
be beneficial in the determination of the origin of ovarian
mucinous malignancy in females (31). In postmenopausal
female patients with GCCT, prophylactic bilateral
oophorectomy, although not based on evidence, should be
considered (18,26).
Finally, appendiceal NETs are asymptomatic. The
symptoms resemble those of acute appendicitis. Since
the diagnosis is usually established after appendectomy,
appendectomy materials should be examined carefully.
GCCTs follow a more aggressive course; thus, it is required
to be more careful in the diagnosis.
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